Related Experiment Videos
[Cholesterol embolism disease: study of 16 cases]
M Ribera Pibernat1, X Bigatà Viscasillas, M J Fuentes González
1Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona.
Revista Clinica Espanola
|March 10, 2001
Summary
Cholesterol embolism syndrome affects elderly patients with atherosclerosis, often triggered by medical procedures or anticoagulation. Early recognition of skin and kidney issues is crucial for management.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Dermatology
Context:
- Cholesterol embolism syndrome (CES) is a rare but serious multisystemic disease.
- It arises from cholesterol crystal embolization to vital organs like the skin, kidneys, and central nervous system.
- Vascular procedures and anticoagulation therapy are known precipitating factors.
Purpose:
- To review and characterize the clinical presentation, risk factors, and outcomes of CES.
- To highlight the diagnostic challenges and importance of early recognition.
Summary:
- This study prospectively reviewed 16 patients diagnosed with CES between 1991 and 1998.
- Patients were elderly (mean age 68) with multiple atherosclerosis risk factors and pre-existing atherosclerotic disease.
- Common clinical manifestations included livedo reticularis, purpuric lesions, purple toes, and skin ulcerations. Renal failure and cerebrovascular accidents were also observed. Diagnosis was confirmed via skin biopsy.
- Precipitating factors such as heparin, coumarins, and vascular procedures were identified in most patients.
Impact:
- The findings underscore the importance of considering CES in elderly patients with atherosclerotic disease presenting with characteristic cutaneous manifestations and renal failure.
- Heightened awareness and preventive measures are essential to reduce the morbidity and mortality associated with this syndrome.
- Early diagnosis and management can potentially mitigate severe complications like limb amputation and organ damage.